At the he Intersection on of of Pub ublic Health h an and H - - PowerPoint PPT Presentation

at the he intersection on of of pub ublic health h an and
SMART_READER_LITE
LIVE PREVIEW

At the he Intersection on of of Pub ublic Health h an and H - - PowerPoint PPT Presentation

At the he Intersection on of of Pub ublic Health h an and H Heal ealth Car are: e: CD CDCs Nationa onal Ast sthma Con ontrol ol Progr gram Shirl Ellis Odem Maureen Wilce Elizabeth Herman Asthm hma I Ini nitiative of of


slide-1
SLIDE 1

At the he Intersection

  • n of
  • f Pub

ublic Health h an and H Heal ealth Car are: e: CD CDC’s Nationa

  • nal

Ast sthma Con

  • ntrol
  • l Progr

gram

Shirl Ellis Odem Maureen Wilce Elizabeth Herman

Asthm hma I Ini nitiative of

  • f Michi

higa gan n Partne nershi hip F For

  • rum

um June 3, 2016

National Center for E nvironmental Health Agency for Toxic S ubstances and Disease R egistry
slide-2
SLIDE 2

Dis iscla laim imer

The he i inf nformation in t this pres esen entation d does es not n nec eces essar arily rep epres esen ent t the o e official al p policy o

  • f t

the e Cen enter ers for Diseas ease e Control an and Prevention. n.

slide-3
SLIDE 3

Topics C Cover ered ed

 Overview of CD

CDC C F FOA E EH14-1404 1404: Compr prehe hens nsive Asthm hma Cont ntrol t thr hrough ugh Evide denc nce-bas ased ed Strat ateg egies es an and Public H Heal ealth –Heal ealth C Car are e Col

  • llabor
  • ration
  • n

 Funde

unded d Non n Governm nmental O Orga gani nizations ns

 Michi

higa gan’s Asthm hma P Progr gram E Evalua uation n Hig ighlig lights

 CD

CDC’ C’s 6| 6|18 18 Init itia iativ ive

slide-4
SLIDE 4

Comprehensive Asthma Control through h Evidence-bas ased ed Strateg egies es an and Public H Heal ealth – Heal ealth C Car are e Collab aboration

 FOA EH

EH14-1404 1404

  • Aligns with CDC strategic directions to

strengthen collaboration between public health and healthcare

  • Aligns with IOM’s Primary Care and Public

Health: Exploring Integration to Improve Population Health

slide-5
SLIDE 5

Comprehensive Asthma Control through h Evidence-bas ased ed Strateg egies es an and Public H Heal ealth – Heal ealth C Car are e Collab aboration

 The purpose of this FOA is to

maximize the reach, impact, efficiency and sustainability of comprehensive asthma control services.

slide-6
SLIDE 6

Ke Key Strategy: Infrastruc uctur ure

Inf nfrastruc uctur ure

Occurs Statewide - Ongoing and tailored to support the Services and Health Systems strategies.

Leadership Strategic Partnerships Strategic Communication Surveillance E valuation

slide-7
SLIDE 7

Key ey S Strat ategy: Ser ervices es

Ser ervices es

School-based Services SME and link with health care services first, then

  • ther services (staff training, environmental,

policy) as appropriate Home-based Services Assure interventions provide SME, identify and act on appropriate triggers, link with medical care and refer to social services as needed

slide-8
SLIDE 8

Key ey S Strat ategy: H Heal ealth S System ems

Heal ealth System ems

Promote guidelines based care through QI, decision support tools, EHR , quality measures, team-based care F acilitate/Make the case for providing or linking to and reimbursing for SME and home-based trigger reduction services

slide-9
SLIDE 9

St Step-Wise se Approac ach: Complem emen entar ary Evidence-Bas ased ed I Inter erven entions

Guidelines Based Medical Management Self Management Education Multi-component multi-trigger home- based interventions Comprehensive Asthma Control Services

slide-10
SLIDE 10

Outco comes

Sh Short-term o

  • utco

comes s – Improved collaborations, strategic communications and increasing self-management knowledge. Inter ermed ediate o

  • utcomes

es – Increased self- management behaviors and increased asthma management capacity within schools, community and health care settings. Lo Long-term o

  • utco

comes s – R educed deaths and hospitalizations from asthma, increased quality

  • f life of people living with asthma and sustain

comprehensive asthma control services.

slide-11
SLIDE 11

States

slide-12
SLIDE 12

Non-Governmental Organization (NGOs)

 In 2015 NACP funded 4 NGOs to implement

communication and education strategies to audiences, including people experiencing a high burden of asthma, caregivers, school personnel, employers, and other supporters.

  • The American Lung Association (ALA)
  • The Asthma and Allergy Foundation of American

(AAFA)

  • The National Environmental Education Foundation

(NEEF)

  • The Asthma and Allergy Network (AAN)
slide-13
SLIDE 13

Non-Governmental Organization (NGOs): ALA

 (ALA

LA) - Conducting key informant discussions with adults, community health workers, housing providers and employers to understand their current knowledge, attitudes, practices, and barriers to recognizing and requesting appropriate care and to living and working in supportive environments.

 (AAFA) - Conducting environmental scan and

querying peer-reviewed studies and gray literature for current evidence on asthma interventions.

slide-14
SLIDE 14

THANK YOU

 Questions will be held until all CDC

Guest present.

slide-15
SLIDE 15

Program E valuation and the National Asthma Control Program

Maureen Wilce Evaluation Technical Advisor

slide-16
SLIDE 16

What is Program E valuation?

  • Evaluation is the systematic investigation of

the structure, activities, or outcomes of asthma control programs.

  • Program evaluation explores how and why

those activities and outcomes are occurring

  • It builds on existing program strengths and

promotes effective change

slide-17
SLIDE 17

Benefits of Program E valuation

  • Provides information to guide and advocate for

program improvement

  • Validates successes
  • Systematizes good management practices
  • Even a little can go a long way
slide-18
SLIDE 18

Quite S imple R eally….

  • Are we doing the right things?
  • Are we doing things right?
slide-19
SLIDE 19

E valuation: Locally Owned & Operated

“Evaluation is something you do, not something that is done to you” Who are the stakeholders for the program evaluation?

  • Those interested in program operations
  • Those served or affected by program
  • Those who will make decisions based on evaluation

findings to improve or enhance program

19
slide-20
SLIDE 20

Involving Stakeholders Throughout the Evaluation

  • Describing the program and context
  • Prioritizing evaluation questions
  • Collecting data
  • Interpreting findings and developing

recommendations

  • Implementing results
slide-21
SLIDE 21

CDC’ Framework for Program Evaluation in Public Health

Standards Utility Feasibility Propriety Accuracy Engage stakeholders

Steps

Describe the program Gather credible evidence Focus the Evaluation design Justify conclusions Ensure use and share lessons learned
slide-22
SLIDE 22

Using E valuation to Improve Programs

  • Highlight effective program components

– Recognize achievements – Replicate successes

  • Assess and prioritize needs
  • Target program improvements
  • Advocate for the program
slide-23
SLIDE 23
slide-24
SLIDE 24

Res esources es

 CDC F

Framewor

  • rk for
  • r P

Progr

  • gram Evalua

uation

  • n in

n Pub ublic H Health h

  • http://www.cdc.gov/eval/framework/index.htm

 Prac

actical al Evalua uation U

  • n Using

ng the he CDC Evalua uation F

  • n Framewor
  • rk—A W

Web ebinar ar Ser eries es

  • 5 webinars with expert evaluators and tutorials for self learning
  • http://www.cdc.gov/asthma/program_eval/evaluation_webinar.htm

 Learni

ning ng and nd Grow

  • wing t

ng thr hrough

  • ugh Evalua

uation

  • n
  • 6 Modules covering evaluation planning and implementation
  • http://www.cdc.gov/asthma/program_eval/guide.htm
slide-25
SLIDE 25

CDC 6|18 INITIATIVE

ACCELERATING EVIDENCE INTO ACTION:

CONTROL ASTHMA

Elizabeth Herman, MD, MPH Senior Scientist Air Pollution and Respiratory Health Branch Division of Environmental Hazards and Health Effects National Center for Environmental Health

slide-26
SLIDE 26

Improve health security at home and around the world Better prevent the leading causes of illness, injury, disability, and death Strengthen public health – health care collaboration

CDC Strategic Directions

November 2015, Pg.26
slide-27
SLIDE 27

CDC Purchasers, Payers, and Providers

Identify evidence-based prevention interventions associated with high-burden conditions Finance and deliver care

Accelerate Evidence Into Action

November 2015, Pg.3
slide-28
SLIDE 28

3 Buckets of Prevention

Public Health

Health Care Innovative Clinical Prevention Traditional Clinical Prevention

Increase the use of evidence-based services Provide services
  • utside the clinical
setting

Total Population or Community-Wide Prevention

Implement interventions that reach whole populations

1 2 3

November 2015, Pg.28
slide-29
SLIDE 29

The “6 |18” Initiative

Goals: Provide partners with rigorous evidence to inform their decisions to have the greatest health and cost impact. Facilitate partner implementation. Improve population health through Increased coverage, access, utilization, and quality of prevention

6 18

High-burden health conditions

|

Evidence-based interventions that can improve health and save money

November 2015, Pg.11
slide-30
SLIDE 30 11
slide-31
SLIDE 31

Asthma’s Impact on the Nation

Aligning Burden of Disease with Target Population

  • Over 22 million affected
  • Costs ~$63 billion annually
  • Higher prevalence: Black Americans (9.9%),

Hispanics of Puerto Rican descent (14.6%), <100% of federal poverty level (10.9%)

  • Asthma burden
  • 1.8 million emergency department (ED) visits
  • 439,000 hospitalizations
  • About 9 people die from asthma each day
  • Burden can be reduced by controlling asthma

Target Population: Persons at high risk of ED visits or hospitalizations for asthma

Sources: http://www.cdc.gov/asthma/most_recent_data.htm; Jang J et al., Ann Allergy Asthma Immunol, 2013; http://www.cdc.gov/asthma/impacts_nation/asthmafactsheet.pdf
slide-32
SLIDE 32

Int Promote evidence-based medical management following 2007 NAEPP guidelines Expand access to intensive self-management education Expand access to home visits by licensed professionals or qualified lay health workers Promote strategies that improve access and adherence to asthma medications and devices

Sources: http://www.cdc.gov/sixeighteen/asthma/index.htm; Taitel MS et al., JACI, 1995; KarnickP et al., J Asthma, 2007; Nurmagambetov TA et al., AJPM, 2011;Meyerson KL, Nurs Clin North Am, 2013 NAEPP, National Asthma Education and Prevention Program; ROI, return on investment

6|18 Asthma Interventions and Evidence

Reported ROI $3–4 per $1 $2–44 per $1 $2–14 per $1

slide-33
SLIDE 33 Key Accomplishments Lessons Learned
  • Established and published evidence base and economic evidence for this approach
  • National Governors Association Paper “Health Investments That Pay Off: Strategies
for Addressing Asthma in Children”
  • CDC’s National Asthma Control Program White Paper “Developing a Business Case
for Asthma Services in Your State”
  • Both cost and quality can be valuable to health plans
  • Building on existing partnerships and infrastructure can facilitate progress
  • Using health plan analytics can be helpful to identify those at high risk
  • Targeting individuals at higher risk can yield a higher ROI
slide-34
SLIDE 34

Payer Collaboration Case Study

  • First agreement between community asthma coalition and health plan to reimburse home visits

at the Medicaid rate for skilled nursing visits (1999)

  • Services provided:
  • home-based self-management education
  • home environmental assessments
  • resources to reduce exposures to environmental asthma triggers
  • Utilization data showed reductions in asthma-related ED visits and hospitalizations
  • Return on investment of $2.10 for every $1 of program costs
  • As a result of the success of this partnership, the Michigan Department of Health and Human

Services convened a payer summit in 2008 where insurers agreed to reimburse asthma self-management education home visits, expanding access to asthma home visits in the state

Sources: http://www.cdc.gov/asthma/pdfs/Asthma_Reimbursement_Report.pdf; http://www.cdc.gov/policy/hst/statestrategies/asthma/index.html; Meyerson KL, Nurs Clin North Am, 2013
slide-35
SLIDE 35 For more information please contact Centers for Disease Control and Prevention 1600 Clifton Road NE, Atlanta, GA 30333 Telephone, 1-800-CDC-INFO (232-4636)/TTY: 1-888-232-6348 E-mail: cdcinfo@cdc.gov Web: www.cdc.gov The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

THANK YOU!

For more information please contact Centers for Disease Control and Prevention 1600 Clifton Road NE, Atlanta, GA 30333 Telephone, 1-800-CDC-INFO (232-4636)/TTY: 1-888-232-6348 E-mail: cdcinfo@cdc.gov Web: www.cdc.gov The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.